Metabolic syndrome in type 1 diabetes and its association with diabetes complications
Aim To assess the prevalence of metabolic syndrome in type 1 diabetes, and its age‐related association with diabetes complications. Methods Australian National Diabetes Information Audit and Benchmarking (ANDIAB) was a well‐established quality audit programme. It provided cross‐sectional data on peo...
Gespeichert in:
Veröffentlicht in: | Diabetic medicine 2021-02, Vol.38 (2), p.e14376-n/a |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Aim
To assess the prevalence of metabolic syndrome in type 1 diabetes, and its age‐related association with diabetes complications.
Methods
Australian National Diabetes Information Audit and Benchmarking (ANDIAB) was a well‐established quality audit programme. It provided cross‐sectional data on people attending specialist diabetes services across Australia. We determined the prevalence of metabolic syndrome (WHO criteria) in adults with type 1 diabetes and its associations with diabetes complications across age groups.
Results
Metabolic syndrome prevalence was 30% in 2120 adults with type 1 diabetes. Prevalence increased with age: 21% in those aged 60 years (P |
---|---|
ISSN: | 0742-3071 1464-5491 |
DOI: | 10.1111/dme.14376 |